Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02563860 · ClinicalTrials.gov registry record · Phase 2

Pharmacological Treatment of Rett Syndrome With Statins

A Phase 2 study, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target

NCT02563860 is a Phase 2 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02563860, a Phase 2 study, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target

Study Summary

This is a phase 2 , open label, dose escalating study of Lovastatin in Rett syndrome.

Interventions

  • DRUG Lovastatin

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-07
Est. Completion 2016-07
Phase Phase 2

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT02563860

The ClinicalTrials.gov registry entry for NCT02563860 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Lovastatin is the first listed.

NCT02563860 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02563860 about?

NCT02563860 is a clinical study titled "Pharmacological Treatment of Rett Syndrome With Statins". This is a phase 2 , open label, dose escalating study of Lovastatin in Rett syndrome.

What is the current status of trial NCT02563860?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2015-07. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02563860?

The interventions under investigation include: Lovastatin (DRUG).

Who is sponsoring clinical trial NCT02563860?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.